CEP 2.0: Insights into Inspection Reports
![Drug Master File Procedures in the EU, the US and Japan - Live Online Training](files/eca/userImages/training.img/Z-ECA-Drug-Master-File-Procedures-LOT.jpg)
Recommendation
17/18 September 2024
With updates on the CEP 2.0!
As part of the implementation of the new "CEP 2.0", the EDQM (European Directorate for the Quality of Medicines & HealthCare) has now published on its website a list of authorities and organizations that have insight into the inspection and assessment reports. With these parties there is either a confidentiality agreement or/and a memorandum of understanding.
Authorities and organizations that have access to both reports (inspection and assessment reports) include, for example, the Brazilian health authority ANVISA as well as the Saudi Arabian health authority SFDA and the WHO.
In contrast, only insights into the inspection reports are available to the following organizations and authorities:
- PIC/S, Switzerland
- MHLW, Japan
- USFDA, USA
The full list of eligible parties can be found on the EDQM website.
Furthermore, reference is again made here to the new requirements for CEP dossiers implemented on 01 June 2023. In a summary, these new requirements are listed and explained, as well as provided with further information and links.
There is also a link to the basic information on the structure and content of the CEP 2.0, as reported in a news in April.
Related GMP News
17.07.2024EMA: Q&A document for "Centralised Procedures" updated again
16.07.2024CMDh/HMA: New Update of the Q&A List on Variations
18.06.2024EDQM: New Guideline for sterile Substances published for Comment
18.06.2024EMA updates IRIS Guide
02.05.2024EDQM: Updated Information on the Quality Overall Summary (Module 2)
02.05.2024EDQM: Manufacturing Sites in CEP 2.0?